×

Oxybutynin therapy

DC
  • US 6,124,355 A
  • Filed: 05/13/1998
  • Issued: 09/26/2000
  • Est. Priority Date: 05/22/1995
  • Status: Expired due to Term
First Claim
Patent Images

1. A sustained-release oxybutynin formulation for oral administration to a patient comprising a therapeutic dose of an oxybutynin selected from the group consisting of oxybutynin and its pharmaceutically acceptable salt that delivers from 0 to 20% of the oxybutynin in 0 to 4 hours, from 20 to 50% of the oxybutynin in 0 to 8 hours, from 50 to 85% of the oxybutynin in 0 to 14 hours, and greater than 75% of the oxybutynin in 0 to 24 hours for treating incontinence in the patient.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×